Spire Healthcare Group PLC header image

Spire Healthcare Group PLC

SPI

Equity

ISIN GB00BNLPYF73 / Valor 24881418

LSE London Stock Exchange, SETS (2026-09-03)
GBP 2.41+2.12%

Spire Healthcare Group PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Spire Healthcare Group PLC, established in 2007 through the acquisition and rebranding of 25 Bupa hospitals, is a prominent independent healthcare provider in the United Kingdom. Listed on the London Stock Exchange and part of the FTSE 250, the company operates 38 hospitals and over 50 clinics, medical centres, and consulting rooms across England, Wales, and Scotland. Spire Healthcare offers a comprehensive range of services, including diagnostics, inpatient, day case, and outpatient care, with specialties in orthopaedics, gynaecology, cardiology, neurology, oncology, and general surgery. Additionally, the group provides private GP services, mental health, dermatological, and musculoskeletal care, and occupational health services to over 800 corporate clients. Notably, Spire is the leading independent provider of knee and hip operations by volume in the UK, underscoring its significant role in the healthcare sector.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

13.9%1Y
11.1%3Y
1.90%5Y

Performance

60.7%1Y
40.6%3Y
35.1%5Y

Volatility

Market cap

1305 M

Market cap (USD)

Daily traded volume (Shares)

2,031,981

Daily traded volume (Shares)

1 day high/low

2.25 / 2.23

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.09%CHF 356.50
Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Ltd. Vijaya Diagnostic Centre Ltd. Valor: 113420241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%INR 1,505.95
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.93%EUR 73.46
Rainbow Childrens Medicare Limited
Rainbow Childrens Medicare Limited Rainbow Childrens Medicare Limited Valor: 118549448
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.79%INR 1,442.05
Concord Biotech Ltd.
Concord Biotech Ltd. Concord Biotech Ltd. Valor: 128746036
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.42%INR 1,448.45
Dr. Agarwal's Health Care Ltd.
Dr. Agarwal's Health Care Ltd. Dr. Agarwal's Health Care Ltd. Valor: 141717620
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.17%INR 512.55
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited Valor: 910581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.38%INR 2,935.35
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 2.30
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.23%EUR 21.95
H. Lundbeck A/S
H. Lundbeck A/S H. Lundbeck A/S Valor: 119252587
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.36%DKK 44.38